14 December 2023
Boston Scientific has received the 2023 Prix Galien Award in France for its FARAPULSE Pulsed Field Ablation (PFA) System, in the Best Medical Device Technology category, for the treatment of atrial fibrillation (AF).
Regarded as one of the global health innovation industry’s most prized honors, the Prix Galien Award recognises outstanding biomedical and medical technology product achievement that improves the human condition.
Boston Scientific team in France accepting Prix Galien at the ceremony.
The Prix Galien Award, named after a renowned physician, honours ground-breaking innovations in health care. This year, over 80 candidates competed for recognition across medical device, eHealth, patient support, medicine, and research categories.
Benefits of the PFA technique
At the heart of the FARAPULSE PFA System lies its unique PFA technology, a groundbreaking innovation that sets a new standard in AF treatment. The technology enables the system to deliver precisely controlled pulses of energy, creating durable lesions without the risks associated with conventional thermal ablation methods1.
“The significance of the FARAPULSE PFA System extends far beyond its technological advancements" says Eve Tabourier, Electrophysiology national sales manager France. "it embodies the very essence of meaningful innovation and sets a new benchmark for innovation in the medical device industry.”
Boston Scientific is committed to advancing cardiac care thanks to the development and commercialisation of the FARAPULSE PFA System, which obtained CE Mark in January 2021 and is commercially available throughout Europe.
1Turagam MK, et al. Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry. Circulation.2023;148:35–46. DOI: 10.1161/ CIRCULATIONAHA.123.064959